This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Jefferies raises price target to 400p from 375p; rating buy | Ashmore |
| Morgan Stanley cuts price target to 1495p from 1670p; rating overweight | Hargreaves Lansdown |
| JPMorgan target price increased to 1030p | Fresnillo |
| JPMorgan target price decreased to 1050p | Betfair Group |
| JPMorgan target price decreased to 95p | Ladrbokes |
| UBS target price increased to 213p | Old Mutual |
| UBS Upgraded to Neutral; target price 360p | BT Group |
| HSBC target price increased to 530p | Aviva |
| HSBC target price increased to 275p | Vodafone |
| HSBC target price increased to 350p | Standard Life |
| HSBC Upgraded to Overweight | Legal & General |
| Jefferies target price increased to 400p | Ashmore Group |
| Sanford C. Bernstein target price increased to 3727p | Astrazenca |
| Sanford C. Bernstein target price decreased to 1524p | GlaxosmithKline |
| Panmure Gordon & Co target price decreased to 400p | PZ Cussons |
| Berenberg Downgraded to Hold | Weir Group |
| Berenberg upgraded to Buy; target price 1485p | Smiths Group |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research